PUBLICATIONS · 29804902
Ribociclib plus endocrine therapy for premenopausal women with hormone-receptor-positive, advanced breast cancer (MONALEESA-7): a randomised phase 3 trial.
Open original source → · Download preserved record
Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.
- Journal
- Lancet Oncol
- Publication date
- 2018 Jul
- First author
- Tripathy D
Publication notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- citation
- Lancet Oncol. 2018 Jul;19(7):850-852. doi: 10.1016/S1470-2045(18)30367-X.
- note
- Source null
- related pmid
- 29804904
- relationship
- Comment in
- citation
- Nat Rev Clin Oncol. 2018 Aug;15(8):470-471. doi: 10.1038/s41571-018-0051-x.
- note
- Source null
- related pmid
- 29872179
- relationship
- Comment in
Authors and identifiers
- name
- Tripathy D
- type
- Author
- name
- Im SA
- type
- Author
- name
- Colleoni M
- type
- Author
- name
- Franke F
- type
- Author
- name
- Bardia A
- type
- Author
- name
- Harbeck N
- type
- Author
- name
- Hurvitz SA
- type
- Author
- name
- Chow L
- type
- Author
- name
- Sohn J
- type
- Author
- name
- Lee KS
- type
- Author
- name
- Campos-Gomez S
- type
- Author
- name
- Villanueva Vazquez R
- type
- Author
Complete bibliographic record and source provenance
- authors
- name
- Tripathy D
- type
- Author
- name
- Im SA
- type
- Author
- name
- Colleoni M
- type
- Author
- name
- Franke F
- type
- Author
- name
- Bardia A
- type
- Author
- name
- Harbeck N
- type
- Author
- name
- Hurvitz SA
- type
- Author
- name
- Chow L
- type
- Author
- name
- Sohn J
- type
- Author
- name
- Lee KS
- type
- Author
- name
- Campos-Gomez S
- type
- Author
- name
- Villanueva Vazquez R
- type
- Author
- bibliography ids
- nci-bib-5070e78aab370dddba549d99
- book metadata
- content sha256
- 415f7b5e21b05a7a38a9192eb1b54c36310650a0fbb9880e535cb1ba4552ef58
- document type
- citation
- dois
- 10.1016/S1470-2045(18)30292-4
- electronic publication date
- display
- 2018 May 24
- precision
- day
- year
- 2018
- evidence scope
- bibliographic_metadata_only
- id
- pubmed:29804902
- immutable id
- pubmed:29804902@415f7b5e21b05a7a38a9192eb1b54c36310650a0fbb9880e535cb1ba4552ef58
- journal
- abbreviation
- Lancet Oncol
- issn electronic
- 1474-5488
- issn print
- 1470-2045
- issue
- 7
- name
- The Lancet. Oncology
- nlm unique id
- 100957246
- pages
- 904-915
- volume
- 19
- languages
- eng
- notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- citation
- Lancet Oncol. 2018 Jul;19(7):850-852. doi: 10.1016/S1470-2045(18)30367-X.
- note
- Source null
- related pmid
- 29804904
- relationship
- Comment in
- citation
- Nat Rev Clin Oncol. 2018 Aug;15(8):470-471. doi: 10.1038/s41571-018-0051-x.
- note
- Source null
- related pmid
- 29872179
- relationship
- Comment in
- outcomes validated
- false
- pmid
- 29804902
- provenance
- batch id
- c4c0356d060413f719c2
- provider
- NCBI PubMed ESummary
- record sha256
- ee6f6d819e16b044c16816b08153453035c8267242c86af80e72544f5b9884c6
- response sha256
- adeb6beaad718f060a94981fd9e96a2eaddc4f781839549cb3e53cba822117c0
- retrieved at
- 2026-09-09T23:47:33.674758+00:00
- publication date
- display
- 2018 Jul
- precision
- month
- year
- 2018
- publication types
- Clinical Trial, Phase III
- Comparative Study
- Journal Article
- Multicenter Study
- Randomized Controlled Trial
- Research Support, Non-U.S. Gov't
- record status
- PubMed - indexed for MEDLINE
- schema version
- 1.0
- title
- Ribociclib plus endocrine therapy for premenopausal women with hormone-receptor-positive, advanced breast cancer (MONALEESA-7): a randomised phase 3 trial.
Preserved source evidence · Not medical advice
Triangle